2023 

Daniel Hoyer 

From Serotonin to Neuropeptides and back: Translational Research in Pharma and Academia 

2021 

Christopher Sobey 

From vasomotor mechanisms to oxidative stress, to inflammation and cardiovascular therapies: With a lot of help from my friends. 

2019 

Patrick Sexton 

Molecular and structural basis of the allosteric control of GPCR phenotype by receptor activity-modifying proteins (RAMPs) 

2017 

Nicholas Buckley 

Optimising medicines for optimal patient outcomes? Perhaps we need more comparative ineffectiveness research! 

2015 

David Le Couteur 

The Greenfields of Geriatric Pharmacology 

2013 

Arthur Christopoulos 

Reciprocal relationships: The role of ‘topography’ in drug discovery 

2011 

Greg Dusting 

Adventures in Pharmacology: From prostaglandins to tissue engineering and a bionic eye 

2009 

Philip Beart 

Peter Mackenzie 

Design and Serendipity in Pursuit of Neuroprotection 

The UDP Glycosyltransferases; a Versatile Defense Against Chemical Insult 

2007 

Michael Roberts 

Seeking to Improve Therapeutic Outcomes Through Research 

2005 

Geoffrey Burnstock 

Purinergic Signalling’: history and therapeutic potential 

2003 

Roger Summers 

The Janus faces of adrenoceptors 

2001 

John O Miners 

The evolution of drug metabolism: Hitchhiking on the technology bandwagon 

1999 

Donald Birkett 

Peripatetic paths in research: from biochemistry via drug metabolism to drug utilisation 

1997 

Bevyn Jarrott 

Design and serendipity in the quest for novel neuroprotective drugs 

1995 

Susan Pond 

Illumination of Therapeutics by Toxicology 

1993 

Graham AR Johnston 

GABA Receptors – As Complex as ABC?